Emtricitabine is one of the best tolerated medicines in HIV care. Most people notice nothing at all, and where someone taking a combination tablet has difficulty, the cause is usually another component.
What happens in the first weeks?
Headache, nausea, tiredness and loose stools occur in a minority and generally settle within two to four weeks. They are mild where they occur. Taking the tablet with food helps some people, though emtricitabine itself does not require it.
What is the distinctive side effect?
A mild darkening of the skin on the palms and the soles of the feet, sometimes also affecting the nails. It occurs in a small proportion of people and more commonly in those with darker skin. It is entirely harmless, does not progress and does not indicate anything going wrong.
Should that darkening prompt any action?
No, beyond mentioning it at your next appointment so it is recorded and not investigated as something else. It is not a sign of liver or kidney problems and it is not a reason to change anything unless you find the appearance troubling, which is a legitimate but uncommon reason.
Does it affect kidneys?
Not meaningfully. Emtricitabine is cleared by the kidneys, so the dose is adjusted where function is reduced, and it is not itself a cause of kidney damage. The kidney monitoring attached to combinations containing it exists because of the tenofovir component.
Does it affect bones?
No. Bone density effects seen with combination tablets relate to tenofovir disoproxil rather than to emtricitabine.
Does it cause weight gain?
Not attributed to it. Weight changes reported with modern regimens have been associated with integrase inhibitors and with tenofovir alafenamide rather than with this component.
What about hepatitis B?
Not a side effect of taking it but of stopping. Emtricitabine suppresses hepatitis B, so abrupt withdrawal in someone with chronic infection can cause a serious flare of liver inflammation. Hepatitis B status is checked before starting for exactly this reason.
Are there rare serious reactions?
Lactic acidosis with liver enlargement has been reported with this class of drug, uncommonly with the newer agents. Severe abdominal pain, unusual breathlessness, marked weakness or persistent vomiting warrant prompt medical attention rather than waiting for an appointment.
What about allergic reactions?
Uncommon. Any rash accompanied by fever, blistering, peeling skin, or involvement of the mouth or eyes is an emergency regardless of which medicine caused it. A mild rash without those features should still be reported so it can be assessed.
How would side effects be picked up?
Blood tests every three to six months covering viral load, kidney and liver function. Most problems appear on a test before anyone notices a symptom, which is why attending appointments matters even when you feel entirely well.
When should you contact your clinic?
Anything lasting beyond a month, anything new and persistent, or anything making you consider stopping. If you are struggling on a combination tablet, it is worth asking which component is likely responsible, since switching one part is often possible without changing the whole regimen.
Do side effects mean it is working?
No, and neither does their absence mean it is not. There is no relationship between how you feel and how effectively HIV is being suppressed or prevented. Blood tests are the only reliable measure.
What if you cannot tolerate the combination?
Say so rather than stopping. Because emtricitabine is rarely the problem, switching the other component frequently resolves it while keeping the regimen otherwise intact. Quietly discontinuing is the outcome worth avoiding.
Should you look side effects up online?
The patient information leaflet lists everything ever reported, including things that occurred once in a trial, which makes it alarming and not very useful for judging likelihood. A clinic pharmacist will tell you which effects are actually common, which are rare and which matter, in about two minutes.
Do effects change over time?
Early effects usually settle within a month. Effects that appear after months or years are less likely to be the drug and worth investigating properly rather than assumed either way. Either pattern is worth reporting rather than absorbing.